P Koch Selected Research

P Koch Research Topics

Disease

6	Hodgkin Disease (Hodgkin's Disease) 02/2007 - 04/2001
4	Neoplasms (Cancer) 12/2011 - 03/2000
3	Lymphoma (Lymphomas) 12/2003 - 01/2001
2	Pain (Aches) 01/2014 - 11/2006
2	Uveitis 01/2013 - 08/2010
2	Hypersensitivity (Allergy) 04/2005 - 04/2000
2	Residual Neoplasm 05/2003 - 09/2001
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 11/2002 - 11/2000
2	Familial primary gastric lymphoma 09/2001 - 03/2000
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 09/2001 - 03/2000
1	Amyloid Plaque 01/2021
1	Scheuermann Disease 04/2016
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2015
1	Glioma (Gliomas) 12/2011
1	Chorioretinitis 06/2011
1	Toxoplasmosis 06/2011
1	Keratoacanthoma 10/2008
1	Bowen's Disease (Disease, Bowen) 10/2008
1	Basal Cell Carcinoma (Rodent Ulcer) 10/2008
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 10/2008
1	Carcinoma (Carcinomatosis) 10/2008
1	Exanthema (Rash) 11/2006
1	Meningioma (Meningiomas) 06/2006
1	Leukemia 11/2002
1	Edema (Dropsy) 11/2002
1	Infertility (Sterility) 09/2001
1	Allergic Contact Dermatitis 02/2001
1	Hereditary Angioedemas 07/2000
1	Eczema 04/2000
1	Hemorrhage 03/2000

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 01/2021 - 08/2001
3	Vincristine (Oncovin)FDA LinkGeneric 02/2004 - 09/2001
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 02/2004 - 09/2001
3	Etoposide (VP 16)FDA LinkGeneric 02/2004 - 04/2001
3	Prednisone (Sone)FDA LinkGeneric 02/2004 - 09/2001
2	Messenger RNA (mRNA)IBA 12/2011 - 10/2008
2	DNA (Deoxyribonucleic Acid)IBA 06/2011 - 03/2000
2	Procarbazine (Matulane)FDA Link 02/2004 - 05/2003
2	Bleomycin (Blenoxane)FDA LinkGeneric 02/2004 - 05/2003
2	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2004 - 05/2003
1	Amyloid beta-PeptidesIBA 01/2021
1	Amyloid (Amyloid Fibrils)IBA 01/2021
1	Peptides (Polypeptides)IBA 01/2021
1	tau Proteins (tau Protein)IBA 01/2021
1	Protons (Proton)IBA 01/2014
1	Protein Tyrosine PhosphatasesIBA 12/2011
1	Immunoglobulin G (IgG)IBA 06/2011
1	Moxifloxacin (Avelox)FDA Link 08/2010
1	Acyclovir (Aciclovir)FDA LinkGeneric 11/2006
1	phenoxyethanol (2-phenoxyethanol)IBA 04/2005
1	1,2-dibromo-2,4-dicyanobutaneIBA 04/2005
1	Methotrexate (Mexate)FDA LinkGeneric 02/2004
1	Ifosfamide FDA LinkGeneric 02/2004
1	Vinblastine (Vinblastine Sulfate)FDA Link 02/2004
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 05/2003
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 11/2002
1	RanGTP-binding protein 17IBA 11/2002
1	beta Adrenergic ReceptorsIBA 11/2002
1	Alkylating AgentsIBA 09/2001
1	Green Fluorescent ProteinsIBA 04/2001
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 04/2001
1	Estradiol (Delestrogen)FDA LinkGeneric 02/2001
1	Norethindrone Acetate (Norlutate)FDA LinkGeneric 02/2001
1	Amino Acids FDA Link 11/2000
1	Complement Inactivating AgentsIBA 07/2000
1	Heparinoids (Heparinoid)IBA 04/2000
1	Heparin (Liquaemin)FDA LinkGeneric 04/2000
1	AnticoagulantsIBA 04/2000
1	lepirudin (Refludan)FDA Link 04/2000
1	HirudinsIBA 04/2000
1	Proline (L-Proline)FDA Link 03/2000

Therapy/Procedure

7	Radiotherapy 02/2007 - 03/2000
4	Drug Therapy (Chemotherapy) 02/2007 - 03/2000
3	Conservative Treatment 12/2003 - 03/2000
2	Therapeutics 09/2001 - 08/2001
1	Contraindications 04/2016
1	Nephrectomy 01/2015
1	Vitrectomy 01/2013
1	Intravenous Administration 11/2006
1	Aftercare (After-Treatment) 09/2001
1	Dexa-BEAM protocol 04/2001
1	Intravenous Injections 04/2000
1	Injections 04/2000